Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism

Journal of Affective Disorders

Volumn 127, Issue 1-3, 2010, Pages 219-229

  Li, Cheng Ta ^a,b   Wang, Shyh Jen ^a   Hirvonen, Jussi ^c   Hsieh, Jen Chuen ^a,b   Bai, Ya Mei ^a,b   Hong, Chen Jee ^a,b   Liou, Ying Jay ^a,b   Su, Tung Ping ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Glucose metabolism; Mechanism; Medication resistant depression; PET; Responder

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; MAJOR DEPRESSION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; ANTIDEPRESSIVE AGENTS; BLOOD GLUCOSE; BRAIN; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DOMINANCE, CEREBRAL; DRUG RESISTANCE; ENERGY METABOLISM; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; REFERENCE VALUES; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 78149358320     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.05.028     Document Type: Article

References (64)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV 1994 American Psychiatric Association Washington D.C.
2. D.H. Avery, P.E. Holtzheimer III, W. Fawaz, J. Russo, J. Neumaier, D.L. Dunner, D.R. Haynor, K.H. Claypoole, C. Wajdik, and P. Roy-Byrne A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression Biol. Psychiatry 59 2006 187 194
3. C. Baeken, R. De Raedt, C. Van Hove, P. Clerinx, J. De Mey, and A. Bossuyt HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging CNS Spectr. 14 2009 439 448
4. R.M. Bagby, N.A. Rector, Z.V. Segal, R.T. Joffe, A.J. Levitt, S.H. Kennedy, and R.D. Levitan Rumination and distraction in major depression: assessing response to pharmacological treatment J. Affect. Disord. 55 1999 225 229
5. L.G. Bretlau, M. Lunde, L. Lindberg, M. Unden, S. Dissing, and P. Bech Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial Pharmacopsychiatry 41 2008 41 47
6. A.L. Brody, S. Saxena, P. Stoessel, L.A. Gillies, L.A. Fairbanks, S. Alborzian, M.E. Phelps, S.C. Huang, H.M. Wu, M.L. Ho, M.K. Ho, S.C. Au, K. Maidment, and L.R. Baxter Jr. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings Arch. Gen. Psychiatry 58 2001 631 640
7. J. Brunelin, E. Poulet, C. Boeuve, H. Zeroug-vial, T. d'Amato, and M. Saoud Efficacy of repetitive transcranial magnetic stimulation (rTMS) in major depression: a review Encephale 33 2007 126 134
8. M.S. Buchsbaum, J. Wu, B.V. Siegel, E. Hackett, M. Trenary, L. Abel, and C. Reynolds Effect of sertraline on regional metabolic rate in patients with affective disorder Biol. Psychiatry 41 1997 15 22
9. S.T. Carmichael, and J.L. Price Architectonic subdivision of the orbital and medial prefrontal cortex in the macaque monkey J. Comp. Neurol. 346 1994 366 402
10. C.S. Carter, and V. van Veen Anterior cingulate cortex and conflict detection: an update of theory and data Cogn. Affect. Behav. Neurosci. 7 2007 367 379
11. O. Devinsky, M.J. Morrell, and B.A. Vogt Contributions of anterior cingulate cortex to behaviour Brain 118 Pt 1 1995 279 306
12. O.T. Dolberg, S. Schreiber, and L. Grunhaus Transcranial magnetic stimulation-induced switch into mania: a report of two cases Biol. Psychiatry 49 2001 468 470
13. W.C. Drevets Prefrontal cortical-amygdalar metabolism in major depression Ann N Y Acad. Sci. 877 1999 614 637
14. W.C. Drevets, J.L. Price, and M.L. Furey Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression Brain Struct. Funct. 213 2008 93 118
15. D. Ebert, H. Feistel, A. Barocka, and W. Kaschka Increased limbic blood flow and total sleep deprivation in major depression with melancholia Psychiatry Res. 55 1994 101 109
16. A. Etkin, and T.D. Wager Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia Am. J. Psychiatry 164 2007 1476 1488
17. A. Fekadu, S.C. Wooderson, K. Markopoulo, C. Donaldson, A. Papadopoulos, and A.J. Cleare What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies J. Affect. Disord. 116 2009 4 11
18. P.B. Fitzgerald, K. Hoy, S. McQueen, J.J. Maller, S. Herring, R. Segrave, M. Bailey, G. Been, J. Kulkarni, and Z.J. Daskalakis A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression Neuropsychopharmacology 34 2009 1255 1262
19. F. Fregni, M.A. Marcolin, M. Myczkowski, R. Amiaz, G. Hasey, D.O. Rumi, M. Rosa, S.P. Rigonatti, J. Camprodon, M. Walpoth, J. Heaslip, L. Grunhaus, A. Hausmann, and A. Pascual-Leone Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation Int. J. Neuropsychopharmacol. 9 2006 641 654
20. K.J. Friston Testing for anatomically specified regional effects Hum. Brain Mapp. 5 1997 133 136
21. K.J. Friston, C.D. Frith, P.F. Liddle, R.J. Dolan, A.A. Lammertsma, and R.S. Frackowiak The relationship between global and local changes in PET scans J. Cereb. Blood Flow Metab. 10 1990 458 466
22. K.J. Friston, C.D. Frith, P.F. Liddle, and R.S. Frackowiak Comparing functional (PET) images: the assessment of significant change J. Cereb. Blood Flow Metab. 11 1991 690 699
23. K.J. Friston, A. Holmes, J.B. Poline, C.J. Price, and C.D. Frith Detecting activations in PET and fMRI: levels of inference and power Neuroimage 4 1996 223 235
24. J.D. Gispert, J. Pascau, S. Reig, R. Martinez-Lazaro, V. Molina, P. Garcia-Barreno, and M. Desco Influence of the normalization template on the outcome of statistical parametric mapping of PET scans Neuroimage 19 2003 601 612
25. L. Grunhaus, P.N. Dannon, S. Schreiber, O.H. Dolberg, R. Amiaz, R. Ziv, and E. Lefkifker Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study Biol. Psychiatry 47 2000 314 324
26. M. Hornig, P.D. Mozley, and J.D. Amsterdam HMPAO SPECT brain imaging in treatment-resistant depression Prog. Neuropsychopharmacol. Biol. Psychiatry 21 1997 1097 1114
27. T. Hosokawa, T. Momose, and K. Kasai Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 243 250
28. C.C. Huang, T.P. Su, and I.K. Shan A case report of repetitive transcranial magnetic stimulation-induced mania Bipolar Disord. 6 2004 444 445
29. N. Kennedy, and K. Foy The impact of residual symptoms on outcome of major depression Curr. Psychiatry Rep. 7 2005 441 446
30. S.H. Kennedy, K.R. Evans, S. Kruger, H.S. Mayberg, J.H. Meyer, S. McCann, A.I. Arifuzzman, S. Houle, and F.J. Vaccarino Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression Am. J. Psychiatry 158 2001 899 905
31. S.H. Kennedy, J.Z. Konarski, Z.V. Segal, M.A. Lau, P.J. Bieling, R.S. McIntyre, and H.S. Mayberg Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial Am. J. Psychiatry 164 2007 778 788
32. T.A. Kimbrell, R.T. Dunn, M.S. George, A.L. Danielson, M.W. Willis, J.D. Repella, B.E. Benson, P. Herscovitch, R.M. Post, and E.M. Wassermann Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers Psychiatry Res. 115 2002 101 113
33. T.A. Kimbrell, T.A. Ketter, M.S. George, J.T. Little, B.E. Benson, M.W. Willis, P. Herscovitch, and R.M. Post Regional cerebral glucose utilization in patients with a range of severities of unipolar depression Biol. Psychiatry 51 2002 237 252
34. S. Kito, K. Fujita, and Y. Koga Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression J. Neuropsychiatry Clin. Neurosci. 20 2008 74 80
35. J.Z. Konarski, S.H. Kennedy, Z.V. Segal, M.A. Lau, P.J. Bieling, R.S. McIntyre, and H.S. Mayberg Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder J. Psychiatry Neurosci. 34 2009 175 180
36. A. Little Treatment-resistant depression Am. Fam. Physician 80 2009 167 172
37. J.T. Little, T.A. Ketter, T.A. Kimbrell, A. Danielson, B. Benson, M.W. Willis, and R.M. Post Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls Psychopharmacol. Bull. 32 1996 629 635
38. J.T. Little, T.A. Ketter, T.A. Kimbrell, R.T. Dunn, B.E. Benson, M.W. Willis, D.A. Luckenbaugh, and R.M. Post Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression Biol. Psychiatry 57 2005 220 228
39. H.S. Mayberg Limbic-cortical dysregulation: a proposed model of depression J. Neuropsychiatry Clin. Neurosci. 9 1997 471 481
40. H.S. Mayberg Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment Br. Med. Bull. 65 2003 193 207
41. H.S. Mayberg, S.K. Brannan, R.K. Mahurin, P.A. Jerabek, J.S. Brickman, J.L. Tekell, J.A. Silva, S. McGinnis, T.G. Glass, C.C. Martin, and P.T. Fox Cingulate function in depression: a potential predictor of treatment response NeuroReport 8 1997 1057 1061
42. H.S. Mayberg, S.K. Brannan, J.L. Tekell, J.A. Silva, R.K. Mahurin, S. McGinnis, and P.A. Jerabek Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response Biol. Psychiatry 48 2000 830 843
43. H.S. Mayberg, M. Liotti, S.K. Brannan, S. McGinnis, R.K. Mahurin, P.A. Jerabek, J.A. Silva, J.L. Tekell, C.C. Martin, J.L. Lancaster, and P.T. Fox Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness Am. J. Psychiatry 156 1999 675 682
44. M.S. Milak, R.V. Parsey, L. Lee, M.A. Oquendo, D.M. Olvet, F. Eipper, K. Malone, and J.J. Mann Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment Psychiatry Res. 173 2009 63 70
45. P.J. Morgane, J.R. Galler, and D.J. Mokler A review of systems and networks of the limbic forebrain/limbic midbrain Prog. Neurobiol. 75 2005 143 160
46. K. Nakamura, R. Kawashima, N. Sato, A. Nakamura, M. Sugiura, T. Kato, K. Hatano, K. Ito, H. Fukuda, T. Schormann, and K. Zilles Functional delineation of the human occipito-temporal areas related to face and scene processing. A PET study Brain 123 Pt 9 2000 1903 1912
47. A. Pascual-Leone, J. Valls-Sole, E.M. Wassermann, and M. Hallett Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex Brain 117 Pt 4 1994 847 858
48. T. Paus, and J. Barrett Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression J. Psychiatry Neurosci. 29 2004 268 279
49. L.J. Porrino, A.M. Crane, and P.S. Goldman-Rakic Direct and indirect pathways from the amygdala to the frontal lobe in rhesus monkeys J. Comp. Neurol. 198 1981 121 136
50. D.O. Rumi, W.F. Gattaz, S.P. Rigonatti, M.A. Rosa, F. Fregni, M.O. Rosa, C. Mansur, M.L. Myczkowski, R.A. Moreno, and M.A. Marcolin Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study Biol. Psychiatry 57 2005 162 166
51. S. Saxena, A.L. Brody, M.L. Ho, N. Zohrabi, K.M. Maidment, and L.R. Baxter Jr. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression Am. J. Psychiatry 160 2003 522 532
52. D.J. Schutter Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis Psychol. Med. 39 2009 65 75
53. I. Sibon, A.P. Strafella, P. Gravel, J.H. Ko, L. Booij, J.P. Soucy, M. Leyton, M. Diksic, and C. Benkelfat Acute prefrontal cortex TMS in healthy volunteers: effects on brain 11C-alphaMtrp trapping Neuroimage 34 2007 1658 1664
54. M. Signorini, E. Paulesu, K. Friston, D. Perani, A. Colleluori, G. Lucignani, F. Grassi, V. Bettinardi, R.S. Frackowiak, and F. Fazio Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping Neuroimage 9 1999 63 80
55. A.M. Speer, T.A. Kimbrell, E.M. Wassermann, J.D.R., M.W. Willis, P. Herscovitch, and R.M. Post Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients Biol. Psychiatry 48 2000 1133 1141
56. T.P. Su, C.C. Huang, and I.H. Wei Add-on rTMS for medication-resistant depression: a randomized, double-blind, sham-controlled trial in Chinese patients J. Clin. Psychiatry 66 2005 930 937
57. S. Surguladze, M.J. Brammer, P. Keedwell, V. Giampietro, A.W. Young, M.J. Travis, S.C. Williams, and M.L. Phillips A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder Biol. Psychiatry 57 2005 201 209
58. Surguladze, S.A., El-Hage, W., Dalgleish, T., Radua, J., Gohier, B., Phillips, M.L., Depression is associated with increased sensitivity to signals of disgust: a functional magnetic resonance imaging study. J Psychiatr Res.
59. C.C. Teneback, Z. Nahas, A.M. Speer, M. Molloy, L.E. Stallings, K.M. Spicer, S.C. Risch, and M.S. George Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS J. Neuropsychiatry Clin. Neurosci. 11 1999 426 435
60. P. Videbech PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review Acta Psychiatr. Scand. 101 2000 11 20
61. E. Watkins, and J.D. Teasdale Adaptive and maladaptive self-focus in depression J. Affect. Disord. 82 2004 1 8
62. M.W. Willis, T.A. Ketter, T.A. Kimbrell, M.S. George, P. Herscovitch, A.L. Danielson, B.E. Benson, and R.M. Post Age, sex and laterality effects on cerebral glucose metabolism in healthy adults Psychiatry Res. 114 2002 23 37
63. J. Wu, M.S. Buchsbaum, J.C. Gillin, C. Tang, S. Cadwell, M. Wiegand, A. Najafi, E. Klein, K. Hazen, W.E. Bunney Jr., J.H. Fallon, and D. Keator Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex Am. J. Psychiatry 156 1999 1149 1158
64. X.M. Zheng Regional cerebral blood flow changes in drug-resistant depressed patients following treatment with transcranial magnetic stimulation: a statistical parametric mapping analysis Psychiatry Res. 100 2000 75 80